SCHEMBL4532108

SCHEMBL4532108

CCOc1[c]ccc(OCC)c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
NQO1 P15559 1/20 0.34
L3MBTL1 Q9Y468 5/20 0.33
KDM4E B2RXH2 4/20 0.33
MAPT P10636 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPK1 P28482 3/20 0.33
HSD17B10 Q99714 2/20 0.33
AOC3 Q16853 2/20 0.33
HPGD P15428 2/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GLA P06280 1/20 0.32
PABPC1 P11940 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
GRK6 P43250 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9244853 0.82 NQO1 (0.36) NQO1TDP1TSHR
SCHEMBL10334834 0.82 ALDH1A1 (0.38) ALDH1A1NQO1L3MBTL1KDM4EMAPT
SCHEMBL285513 0.80 TSHR (0.38) ALDH1A1NQO1L3MBTL1KDM4EMAPT
SCHEMBL11779722 0.78 ALDH1A1 (0.34) ALDH1A1NQO1L3MBTL1KDM4EMAPT
SCHEMBL285182 0.73 ALDH1A1 (0.45) ALDH1A1NQO1L3MBTL1KDM4EMAPT
SCHEMBL10345470 0.73 NCOA1 (0.36) ALDH1A1NQO1KDM4EMAPTMAPK1
SCHEMBL8007834 0.72 SMN1; SMN2 (0.43) ALDH1A1NQO1L3MBTL1KDM4EMAPT
SCHEMBL2456321 0.69 NQO1 (0.36) ALDH1A1NQO1MAPTHTTSMN1; SMN2
SCHEMBL12750190 0.69 L3MBTL1 (0.56) ALDH1A1NQO1L3MBTL1KDM4EMAPT
SCHEMBL9674003 0.69 TSHR (0.40) ALDH1A1L3MBTL1KDM4EMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306122-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY OF TYROSINE AND RAF KINASES MERCK PATENT GMBH (DE) 2009-12-10 US claimed
EP-1856116-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY TYROSINE KINASE AND RAF KINASE MODULATORS Merck Patent GmbH (DE) 2007-11-21 EP claimed
WO-2006094600-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY TYROSINE KINASE AND RAF KINASE MODULATORS MERCK PATENT GMBH (DE) 2006-09-14 WO claimed
EP-1189891-A1 TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF LION Bioscience AG (DE) 2002-03-27 EP claimed
US-6362342-B1 BIOSYNTHESIS; DRUG LIBRARIES LION BIOSCIENCE AG (DE) 2002-03-26 US claimed
WO-2001000594-A1 TRIAZOLE COMPOUNDS AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2001-01-04 WO claimed
US-20090306122-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY OF TYROSINE AND RAF KINASES MERCK PATENT GMBH (DE) 2009-12-10 US disclosed
EP-1856116-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY TYROSINE KINASE AND RAF KINASE MODULATORS Merck Patent GmbH (DE) 2007-11-21 EP disclosed
WO-2006094600-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY TYROSINE KINASE AND RAF KINASE MODULATORS MERCK PATENT GMBH (DE) 2006-09-14 WO disclosed
US-6362342-B1 BIOSYNTHESIS; DRUG LIBRARIES LION BIOSCIENCE AG (DE) 2002-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306122-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINE DERIVATIVES AS KINASE MODULATORS, ESPECIALLY OF TYROSINE AND RAF KINASES TIE1, FER, RET ALDH1A1 3078/4885NQO1 1552/4885L3MBTL1 1908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.